Sensitizing the interdisciplinary team to desensitizations: An alemtuzumab case report.

Introduction: We describe a case of alemtuzumab (Campath®) hypersensitivity requiring desensitization within the medical intensive care unit (MICU) in a patient with T-cell prolymphocytic leukemia.

Case Report: We adopted a desensitization protocol from Gutierrez-Fernandez et al., which included three aliquots (0.

Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime.

Recent reports have demonstrated that vancomycin (VAN) may lead to an increase in the incidence of acute kidney injury (AKI) when it is combined with antipseudomonal beta-lactams. This study compared the incidence of AKI associated with VAN plus piperacillin-tazobactam (TZP) or cefepime (FEP). This was a retrospective, matched cohort study that was conducted at an academic medical center between September 2010 and September 2014 and that included adult patients without severe chronic or structural kidney disease, dialysis, pregnancy, cystic fibrosis, or a hospital transfer receiving TZP-VAN or FEP-VAN for at least 48 h.

Cadmium attenuates the macrophage response to LPS through inhibition of the NF-κB pathway.

Chronic obstructive pulmonary disease (COPD) in the U.S. is primarily caused by cigarette smoking.